Unione Europea - danese - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiske - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Unione Europea - danese - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologiske - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - gliclazid - tabletter med modificeret udløsning - 30 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - terbinafinhydrochlorid - tabletter - 125 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

takeda pharmaceuticals international ag ireland branch - lisdexamfetamindimesilat - kapsler, hårde - 30 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

takeda pharmaceuticals international ag ireland branch - lisdexamfetamindimesilat - kapsler, hårde - 40 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

takeda pharmaceuticals international ag ireland branch - lisdexamfetamindimesilat - kapsler, hårde - 50 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

takeda pharmaceuticals international ag ireland branch - lisdexamfetamindimesilat - kapsler, hårde - 60 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

takeda pharmaceuticals international ag ireland branch - lisdexamfetamindimesilat - kapsler, hårde - 70 mg

Unione Europea - danese - EMA (European Medicines Agency)

teva b.v. - salmeterol xinafoate, fluticasonpropionat - pulmonary disease, chronic obstructive; asthma - medicin for obstruktiv sygdomme, - aerivio spiromax er indiceret til brug hos voksne i alderen 18 år og ældre. asthmaaerivio spiromax er indiceret til regelmæssig behandling af patienter med svær astma, hvor anvendelsen af en kombination produkt (inhaleret binyrebarkhormon og langtidsvirkende β2-agonist) er hensigtsmæssige:patienter, der ikke er tilstrækkeligt kontrolleret på et lavere styrke kortikosteroid kombination produkt orpatients allerede kontrolleres på en høj dosis inhaleret binyrebarkhormon og langtidsvirkende β2-agonist. kronisk obstruktiv lungesygdom (kol)aerivio spiromax er indiceret til symptomatisk behandling af patienter med kol med fev1.